Valuation (21%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -0.25 | 12.37 |
| PEG Ratio (TTM) | -0.03 | 3.86 |
| P/S Ratio (TTM) | 0.04 | 1.45 |
| P/B Ratio (TTM) | 1.01 | -10.33 |
| P/FCF Ratio (TTM) | -0.42 | 19.32 |
| Price to 5YR AVG Earnings Ratio | N/A | 19.61 |
| Price to 5YR AVG FCF Ratio | N/A | 23.63 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -35.26% | 5.16% |
| ROE (TTM) | -176.71% | -76.86% |
| Net Profit Margin (TTM) | -16.67% | 0.27% |
| ROIC 5YR AVG | N/A | 16.21% |
Growth (27%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 6.15% | -45.68% | N/A |
| Revenue | 5.10% | 17.77% | N/A |
| Net Income | 1.65% | -39.09% | N/A |
| Cash Flow | -37.05% | -2,234.99% | N/A |
Health (37%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.49 | 1.36 |
| Quick Ratio (TTM) | 2.27 | 1.26 |
| D/E Ratio (TTM) | 5.91 | -5.07 |
| Interest Coverage (TTM) | -7.68 | 5.15 |
| Piotroski F-Score | 2 | 6 |
| Altman Z-Score | N/A | 2.97 |
| LTL to 5YR AVG FCF | N/A | 7.97 |
| Shares Outstanding Growth 5YR AVG | N/A | -0.83% |